Miragen Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Miragen Therapeutics by Bellevue Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $653k | 30k | 21.78 |
2023-09-30 | $978k | 64k | 15.34 |
2023-06-30 | $1.1M | 44k | 23.79 |
2023-03-31 | $1.2M | 46k | 25.44 |
2022-12-31 | $1.3M | 46k | 29.21 |
2022-09-30 | $946k | 46k | 20.52 |
2022-06-30 | $567k | 49k | 11.57 |